Skip to content

Clinical trials

Phase 2/3 Alzheimer Disease trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 2/3 Status: Unknown status Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20161
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Banner Health1
Federal University of Paraíba1
Maastricht University Medical Center1
Mediforum Ltd., Co.1
National Ageing Research Institute, Australia1
Shandong Luye Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease6
Dementia2
Atherosclerosis1
Brain Diseases1
Central Nervous System Diseases1
Dementia, Vascular1
Lewy Body Disease1
Nervous System Diseases1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.